首页 | 本学科首页   官方微博 | 高级检索  
     

选择性COX-2抑制剂的用药风险与新功用
引用本文:潘献柱,汪思应,王林,程洁. 选择性COX-2抑制剂的用药风险与新功用[J]. 药学进展, 2006, 30(4): 165-170
作者姓名:潘献柱  汪思应  王林  程洁
作者单位:1. 安徽医科大学病理生理学教研室,安徽,合肥,230032
2. 军事医学科学院放射与辐射医学研究所,北京,100850
摘    要:综述近年来国内外有关选择性COX-2抑制剂的潜在用药风险及新功用的报道,为探讨该类药物的发展方向提供参考。选择性COX-2抑制剂是一类新型非甾体抗炎药,由于其胃肠毒性低而倍受关注,但潜在的心血管风险限制了其临床上的应用,此类药物的去留引起了极大争议。

关 键 词:非甾体抗炎药  选择性COX-2抑制剂  风险  功用
文章编号:1001-5094(2006)04-0165-06
收稿时间:2005-11-16
修稿时间:2005-11-16

Potential Risks and Novel Effects of Selective COX-2 Inhibitors
PAN Xian-zhu,WANG Si-ying,WANG Lin,CHENG Jie. Potential Risks and Novel Effects of Selective COX-2 Inhibitors[J]. Progress in Pharmaceutical Sciences, 2006, 30(4): 165-170
Authors:PAN Xian-zhu  WANG Si-ying  WANG Lin  CHENG Jie
Affiliation:1. Department ofPathophysiology, Anhui Medical University, Hefei 230032, China ; 2. Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China
Abstract:The potential risks and novel effects of selective COX-2 inhibitors reported in recent years were reviewed to discuss the development of this kind of drugs. The clinical application of selective COX-2 inhibitors, a class of new NSAIDs with low gastrointestinal toxicity, is limited in view of their potential cardiovascular events, which have aroused grave concern.
Keywords:NSAID   Selective COX-2 inhibitor   Risk   Effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号